Recent Quotes (30 days)

You have no recent quotes
chg | %

Premaitha Health PLC news

   Watch this stock
Showing stories 1 - 10 of about 73   

Articles published

NIPT 9.43 +0.23 (2.51%)
price chart
Premaitha Health
Premaitha Health is a molecular diagnostics company employing next generation DNA analysis technology to develop, manufacture and sell molecular diagnostic products intended to have a major beneficial impact on human health. Premaitha is responsible ...
Premaitha Health signs Investment Agreement with Thermo Fisher Scientific
Premaitha's CE-marked, non-invasive prenatal screening (NIPT) product, the IONA� test, runs on Thermo Fisher's two sequencing instruments, the Ion Proton and Ion Chef.
Premaitha Health PLC 131.7% Potential Upside Indicated by finnCap
Premaitha Health PLC using EPIC/TICKER code LON:NIPT had its stock rating noted as 'Initiates/Starts' with the recommendation being set at 'CORPORATE' this morning by analysts at finnCap.
Levels in Focus on Shares of Premaitha Health PLC (NIPT.L)
At the time of writing, the 14-day ADX for Premaitha Health PLC (NIPT.L) is 15.85. Many technical chart analysts believe that an ADX value over 25 would suggest a strong trend.
SMALL CAP IDEAS: Premaitha Health builds foundations for successful European ...
Very often investors are asked to commit to the long haul when they buy into the latest new thing in the healthcare sector.
Premaitha Health PLC's (LON:NIPT) “Corporate” Rating Reaffirmed at FinnCap
Premaitha Health PLC logo Premaitha Health PLC (LON:NIPT)'s stock had its “corporate” rating restated by equities research analysts at FinnCap in a research note issued to investors on Wednesday, July 12th.
London NHS Trust teams up with Premaitha Health to create the UK's first ...
Premaitha Health plc and St George's University Hospitals NHS Foundation Trust have announced that Premaitha has been awarded the contract to provide its non-invasive prenatal test (NIPT), the IONA� test, to St George's following a competitive tender ...
FinnCap Reaffirms Corporate Rating for Premaitha Health PLC (LON:NIPT)
Premaitha Health PLC logo Premaitha Health PLC (LON:NIPT)'s stock had its “corporate” rating restated by analysts at FinnCap in a research note issued on Wednesday, July 12th.
Analysts See $-0.03 EPS for CASI Pharmaceuticals (CASI); Premaitha Health PLC ...
Among 2 analysts covering Premaitha Health Plc (LON:NIPT), 2 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive.
The Premaitha Health PLC's (LON:NIPT) “Corporate” Rating Reiterated at FinnCap
Premaitha Health PLC (LON NIPT) traded up 1.30% during mid-day trading on Friday, hitting GBX 9.75. 634,647 shares of the stock traded hands.